Drug Shortage Report for OCTREOTIDE ACETATE OMEGA

Last updated on 2023-11-14 History
Report ID 208725
Drug Identification Number 02248640
Brand name OCTREOTIDE ACETATE OMEGA
Common or Proper name Octreotide Acetate Injection 100 MCG/ML
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) OCTREOTIDE
Strength(s) 100MCG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS
Packaging size 5 x 1 mL vial / fiole
ATC code H01CB
ATC description HYPOTHALAMIC HORMONES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2023-11-06
Estimated end date 2023-11-20
Actual end date 2023-11-13
Shortage status Resolved
Updated date 2023-11-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2023-11-14 English Compare
v7 2023-11-13 French Compare
v6 2023-11-13 English Compare
v5 2023-11-07 English Compare
v4 2023-11-06 French Compare
v3 2023-11-06 English Compare
v2 2023-10-31 French Compare
v1 2023-10-31 English Compare

Showing 1 to 8 of 8